Patents by Inventor Alessandro Mazzola

Alessandro Mazzola has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8598232
    Abstract: The present invention is directed to a process for producing non-genotoxic Diacetylrhein (Diacerein), comprising: i) transformation of raw Diacerein (or raw Rhein), into a water-soluble salt; ii) adsorption of the salt Diacerein (or Rhein) solution on a hydrophobic resin; iii) washing with an appropriate solvent to eliminate the impurities (in particular the genotoxic impurities); iv) elution to recover Diacereinor Rhein; v) if the process is applied to Rhein, its transformation to Diacerein by acetylation; vi) acidification of purified Diacerein and its recovery, and drying. The invention is also directed to non-genotoxic Diacerein obtained by the process of the invention, in which the total content of genotoxic impurities is below 1 ppm, and suitable for the preparation of pharmaceutical formulations, in particular capsules, for human and veterinary use, in agreement with the current Health Authorities request.
    Type: Grant
    Filed: November 3, 2009
    Date of Patent: December 3, 2013
    Assignee: Evultis SA
    Inventors: Alessandro Mazzola, Silvia Moiana
  • Publication number: 20110245341
    Abstract: The present invention is directed to a process for producing non-genotoxic Diacetylrhein (Diacerein), comprising: i) transformation of raw Diacerein (or raw Rhein), into a water-soluble salt; ii) adsorption of the salt Diacerein (or Rhein) solution on a hydrophobic resin; iii) washing with an appropriate solvent to eliminate the impurities (in particular the genotoxic impurities); iv) elution to recover Diacereinor Rhein; v) if the process is applied to Rhein, its transformation to Diacerein by acetylation; vi) acidification of purified Diacerein and its recovery, and drying. The invention is also directed to non-genotoxic Diacerein obtained by the process of the invention, in which the total content of genotoxic impurities is below 1 ppm, and suitable for the preparation of pharmaceutical formulations, in particular capsules, for human and veterinary use, in agreement with the current Health Authorities request.
    Type: Application
    Filed: November 3, 2009
    Publication date: October 6, 2011
    Applicant: EVULTIS SA
    Inventors: Alessandro Mazzola, Silvia Moiana
  • Patent number: 7678923
    Abstract: Method for synthesising 1-aryl-4-(imidazol-2-yl)-3-alkyl-1H-pyrazole derivatives from 1-aryl-3-alkyl-1H-pyrazo-line-5-one derivatives.
    Type: Grant
    Filed: April 9, 2004
    Date of Patent: March 16, 2010
    Assignee: EVULTIS
    Inventors: Alessandro Mazzola, Giovanni Sanso
  • Publication number: 20070155811
    Abstract: Method for synthesising 1-aryl-4-(imidazol-2-yl)-3-alkyl-1H-pyrazole derivatives from 1-aryl-3-alkyl-1H-pyrazo-line-5-one derivatives.
    Type: Application
    Filed: April 9, 2004
    Publication date: July 5, 2007
    Applicant: EVULTIS
    Inventors: Alessandro Mazzola, Giovanni Sanso